IPP Bureau
Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity
By IPP Bureau - April 29, 2022
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
AstraZeneca expands its ‘Young Health Program’ in Delhi
By IPP Bureau - April 29, 2022
For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases
Lupin Diagnostics launches reference laboratory in Guwahati, Assam
By IPP Bureau - April 29, 2022
It is expanding the diagnostics business footprint in North East India
Medikabazaar teams up with India Health Link
By IPP Bureau - April 29, 2022
To extend the nationwide distribution network for the availability of its proprietary & award-winning HPod for corporates & doctors’ clinics, thereby strengthening India’s phygital wellness ecosystem
Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar
By IPP Bureau - April 29, 2022
The plant is expected to start commercial operations from Q4FY24
Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials
By IPP Bureau - April 28, 2022
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
Dr Vijay Shetty creates an alternative to x-ray examination
By IPP Bureau - April 28, 2022
The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated
Beta Drugs announces oultook for FY 22-23
By IPP Bureau - April 28, 2022
The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
Cipla bags Pharma Leader of the Year award
By IPP Bureau - April 28, 2022
Glenmark Pharmaceuticals won Innovation of the Year award
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
By IPP Bureau - April 28, 2022
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Diadem announces publication of peer-reviewed article on Alzheimer’s disease
By IPP Bureau - April 28, 2022
It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease
Ross Prize awarded to mRNA technology, Covid-19 vaccine innovators
By IPP Bureau - April 28, 2022
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
Kapruvia approved by European Commission for hemodialysis patients
By IPP Bureau - April 28, 2022
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
Sanofi continues to deliver strong business
By IPP Bureau - April 28, 2022
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Airtel, Apollo Hospitals, and Cisco join forces for 5G connected ambulance
By IPP Bureau - April 28, 2022
When a critical patient is en-route to the hospital and every second makes a difference, the 5G Connected ambulance acts as an extension of the emergency room
